Company / Inventory per Share
BIOCRYST PHARMACEUTICALS INC Inventory per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Inventory per Share
$0.02
FY2025
5-year range
$0.02 / $0.15
FY2021-FY2025
Trend
-36.9%
vs FY2024
Sector context
#98 of 105
Health Care
What the data says
Among 105 Health Care companies, BIOCRYST PHARMACEUTICALS INC is in the bottom 7% for inventory per share. Inventory per Share has fluctuated over the past 9 years, ranging from $0.00 in FY2019 to $0.15 in FY2023.
Based on SEC 10-K filings.
0.02 in FY2025 with a 5-year CAGR of -10.1%.
Declined from $0.15 to $0.02 over the past 2 years.
Health Care sector context is included.
Inventory per Share over time
Growth rates
- 3-Year CAGR
- -45.0%
- 5-Year CAGR
- -10.1%
- 10-Year CAGR
- -
Sector benchmark
Bottom 7% in Health CareTop 93% of 105This company $0.02 Sector average $30.82
▼
-99.9% below sector average
Key checks
Key Insights
- In FY2025, inventory per share decreased 36.9% year-over-year.
- Ranks #98 out of 105 companies in the Health Care sector.
- Peak inventory per share was recorded in FY2023.
- Lowest inventory per share in the period was in FY2019.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Inventory per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.02 | -36.9% |
| FY2024 | $0.04 | -73.8% |
| FY2023 | $0.15 | +0.8% |
| FY2022 | $0.15 | +68.0% |
| FY2021 | $0.09 | +109.5% |
| FY2020 | $0.04 | - |
| FY2019 | $0.00 | -100.0% |
| FY2018 | $0.02 | - |
| FY2017 | - | - |
| FY2016 | $0.01 | -69.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026